TiFFANY TR
Not Applicable
Completed
- Conditions
- solid malignancies
- Registration Number
- JPRN-jRCT1080224720
- Lead Sponsor
- ational Cancer Center Hospital East
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- completed
- Sex
- All
- Target Recruitment
- 26
Inclusion Criteria
Patients enrolled in treatment group in 'A multicenter Phase II basket-type clinical trial to evaluate efficacy and safety of TAS-120 in patients with advanced solid malignancies with FGFR alterations in circulating tumor DNA(TiFFANY study)'
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method other<br>Immunohistochemistry<br>In situ hybridization<br>Reverse Phase Protein Array<br>Targeted sequencing<br>RNA-seq<br>Digital sequencing of ctDNA (Guardant360)<br>Functional analysis (in vitro and in vivo)
- Secondary Outcome Measures
Name Time Method other<br>-